Gemzar and condition aggravated Patient Reports February 13, 2012

Gemzar Side Effects Report #5984012-2
Gemzar side effect was reported by a Physician from FRANCE on Nov 26, 2008. Male patient, 60 years of age, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, cytolytic hepatitis, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with PLATINUM COMPOUNDS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4642562-5
Gemzar side effect was reported by a Physician from on Apr 01, 2005. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, biliary tract infection, condition aggravated, decreased appetite, malignant neoplasm progression, pancreatic carcinoma stage iv, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with LOXONIN, SELBEX, LENDORM, URSODIOL, PURSENNID. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4855684-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 29, 2005. Male patient, 74 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, cholangitis acute, condition aggravated, disseminated intravascular coagulation, jaundice , malignant neoplasm progression, pancreatic carcinoma, pleural effusion. Gemzar dosage: unknown. During the same period patient was treated with OMEPRAL, PRIMPERAN, AMLODIN, MAGLAX, LAXOBERON, GASMOTIN. Patient was hospitalized. Patient died on 08/08/2004.

Gemzar Side Effects Report #4853350-9
Gemzar side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 72 years of age, weighting 123.0 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspergillosis, c-reactive protein increased, candidiasis, condition aggravated, fungus serology test positive, laboratory test interference, pneumonia aspiration, pneumonia klebsiella, pneumonitis. Gemzar dosage: 1100 MG, OTHER, INTRAVENOUS. During the same period patient was treated with KYTRIL, DECADRON, FAMOTIDINE. Patient died on 08/15/2005.


Gemzar Side Effects Report #5015996-7
Gemzar side effect was reported by a Physician from JAPAN on May 10, 2006. Male patient, 71 years of age, weighting 134.5 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, hemiplegia, pneumonitis, respiratory failure, urticaria. Gemzar dosage: 1200 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DECADRON SRC, KYTRIL, LOCHOL, NORVASC, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4551258-X
Gemzar side effect was reported by a Health Professional from on Dec 21, 2004. Male patient, 64 years of age, weighting 147.7 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, haematoma, haemoglobin decreased, jaundice cholestatic, malignant neoplasm progression, pyrexia, venous thrombosis limb. Gemzar dosage: 1000MG/M2 OTHER. During the same period patient was treated with MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4851375-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 18, 2005. Male patient, 60 years of age, weighting 135.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, condition aggravated, cough, dyspnoea, gastritis, gastrointestinal haemorrhage, malignant ascites, malignant pleural effusion. Gemzar dosage: 1000 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PENTAZOCINE LACTATE, NSAID, OXYCODONE, MORPHINE. Patient died.

Gemzar Side Effects Report #4844837-3
Gemzar side effect was reported by a Physician from JAPAN on Nov 09, 2005. Male patient, 84 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, condition aggravated, constipation , decreased appetite, fat necrosis, pancreatic haemorrhage, pancreatic pseudocyst, pancreatitis acute. Gemzar dosage: 1000 MG, OTHER, INTRAVENOUS. Patient died on 09/18/2005.

Gemzar Side Effects Report #5026334-8
Gemzar side effect was reported by a Physician from JAPAN on May 25, 2006. Male patient, 71 years of age, weighting 134.5 lb, was diagnosed with pancreatic carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, hemiplegia, pneumonitis, urticaria, white blood cell count increased. Gemzar dosage: 1200 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DECADRON SRC, KYTRIL, LOCHOL, NORVASC, ALLOPURINOL. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4870509-5
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 09, 2005. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, duodenitis, fatigue, gastritis, haematocrit decreased, orthostatic hypotension, recall phenomenon, upper gastrointestinal haemorrhage. Gemzar dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4832377-7
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2005. Male patient, 73 years of age, weighting 184.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, dyspnoea, malignant neoplasm progression, metastases to liver, oedema peripheral, oxygen saturation decreased, pancreatic carcinoma, pneumonia . Gemzar dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4950020-3
Gemzar side effect was reported by a Pharmacist from JAPAN on Feb 22, 2006. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, retinal exudates. Gemzar dosage: 800 MG/M2, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #5030749-1
Gemzar side effect was reported by a Pharmacist from JAPAN on June 05, 2006. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: carbohydrate antigen 19-9 increased, cerebral infarction, condition aggravated, gait disturbance. Gemzar dosage: 800 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with NASEA, AMLODIPINE BESYLATE. Patient recovered.

Gemzar Side Effects Report #4662767-7
Gemzar side effect was reported by a Physician from on Apr 20, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemolytic anaemia, haemolytic uraemic syndrome, haemorrhagic diathesis, international normalised ratio increased, liver disorder. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with KYTRIL, DECADRON, SULPERAZON. Patient recovered.


Gemzar Side Effects Report #4770912-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 29, 2005. Male patient, 72 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary tract infection, condition aggravated, disseminated intravascular coagulation, rash . Gemzar dosage: 200 MG OTHER. During the same period patient was treated with CLINDAMYCIN, ROCEPHIN, MIRACLID, ANTITHROMBIN III. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4776367-1
Gemzar side effect was reported by a Physician from JAPAN on Sept 05, 2005. Male patient, 72 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary tract infection, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, haemorrhage, international normalised ratio increased, platelet count decreased, prothrombin time prolonged, pyrexia. Gemzar dosage: 200 MG OTHER. During the same period patient was treated with CLINDAMYCIN, ROCEPHIN, MIRACLID, ANTITHROMBIN III. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4607544-8
Gemzar side effect was reported by a Physician from on Feb 24, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain , blood pressure increased, condition aggravated, creatinine renal clearance decreased, haemolytic uraemic syndrome, iron deficiency anaemia, malignant neoplasm progression, marrow hyperplasia, oedema peripheral. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.

Gemzar Side Effects Report #5485631-2
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4815007-X
Gemzar side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, condition aggravated. Gemzar dosage: 1000 MG OTHER. Patient recovered.


Gemzar Side Effects Report #4662773-2
Gemzar side effect was reported by a Health Professional from on Apr 22, 2005. Male patient, 61 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, constipation , eating disorder . Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with MORPHINE ELIXIR, HUMULIN R, ROHYPNOL. Patient recovered.

Gemzar Side Effects Report #5055323-2
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2006. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , activities of daily living impaired, ascites, atelectasis, computerised tomogram abnormal, condition aggravated, depressed level of consciousness, disease progression, dyspnoea. Gemzar dosage: 1200 MG, INTRAVENOUS. During the same period patient was treated with KYTRIL, DECADRON #, RINDERON, ETODOLAC, PARIET, MUCOSTA, THEOLONG, SPIROPENT. Patient was hospitalized. Patient died on 05/11/2006.

Gemzar Side Effects Report #5030179-2
Gemzar side effect was reported by a Physician from JAPAN on May 26, 2006. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , activities of daily living impaired, ascites, asthenia, atelectasis, condition aggravated, depressed level of consciousness, emphysema, gastric ulcer haemorrhage. Gemzar dosage: 1200 MG, OTHER, INTRAVENOUS. During the same period patient was treated with KYTRIL, DECADRON #, BETAMETHASONE, ETODOLAC, PARIET, MUCOSTA, THEOLONG, SPIROPENT. Patient was hospitalized. Patient died on 05/11/2006.

Gemzar Side Effects Report #4714125-4
Gemzar side effect was reported by a Physician from JAPAN on June 23, 2005. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, anorexia, bacteria blood identified, catheter sepsis, condition aggravated, depressed level of consciousness, disseminated intravascular coagulation, septic shock. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5048811-6
Gemzar side effect was reported by a Physician from GERMANY on June 19, 2006. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, pancytopenia, paraneoplastic syndrome, systemic lupus erythematosus. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. During the same period patient was treated with NEXIUM, KREON. Patient recovered.


Gemzar Side Effects Report #4994339-9
Gemzar side effect was reported by a Physician from GERMANY on Apr 25, 2006. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, erythema, pancytopenia, systemic lupus erythematosus. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #5117506-2
Gemzar side effect was reported by a Physician from JAPAN on Sept 08, 2006. Female patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, back pain , blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, carcinoembryonic antigen increased, condition aggravated, gamma-glutamyltransferase increased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, GLYBURIDE, VOLTAREN. Patient was hospitalized. Patient died on 11/17/2003.

Gemzar Side Effects Report #5053362-9
Gemzar side effect was reported by a Physician from JAPAN on June 21, 2006. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, asthenia, back pain , carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, condition aggravated, decreased appetite, hiccups, jaundice . Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #5072549-2
Gemzar side effect was reported by a Physician from JAPAN on July 20, 2006. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, asthenia, back pain , carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, condition aggravated, decreased appetite, hiccups, jaundice . Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4777830-X
Gemzar side effect was reported by a Physician from JAPAN on Aug 31, 2005. Male patient, 45 years of age, weighting 138.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, condition aggravated, fatigue, febrile neutropenia, hepatic failure, metastases to liver, pancytopenia, pharyngolaryngeal pain. Gemzar dosage: 1776 MG OTHER. During the same period patient was treated with CISPLATIN, URSOSAN, SULPERAZON, NOVAMIN, GRANISETRON, DEXAMETHASONE. Patient was hospitalized. Patient died on 12/05/2003.


Gemzar Side Effects Report #4937456-1
Gemzar side effect was reported by a Physician from JAPAN on Feb 09, 2006. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure decreased, condition aggravated, cough, nasopharyngitis, nausea , neisseria infection, sepsis , stridor, white blood cell count decreased. Gemzar dosage: 1200 MG, OTHER, INTRAVENOUS. Patient was hospitalized. Patient died on 01/30/2006.

Gemzar Side Effects Report #5078074-7
Gemzar side effect was reported by a Physician from JAPAN on July 25, 2006. Female patient, 71 years of age, weighting 85.10 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, delirium, pleural effusion, pneumonitis, psychotic disorder , pulmonary oedema, pyrexia. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, FENTANYL, NORTRIPTYLINE, ENALAPRIL MALEATE, WARFARIN, METILDIGOXIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5166926-9
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2006. Female patient, 77 years of age, weighting 103.4 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, lymphocyte stimulation test positive, pigmentation disorder. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with VINORELBINE, EPOETIN ALFA, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ONDANSETRON, DIAMOX #, SPIRONOLACTONE, ALFAROL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5179480-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2006. Female patient, 77 years of age, weighting 103.4 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, lymphocyte stimulation test positive, pigmentation disorder. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with VINORELBINE, EPOETIN ALFA, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ONDANSETRON, DIAMOX #, SPIRONOLACTONE, ALFAROL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4876151-4
Gemzar side effect was reported by a Pharmacist from JAPAN on Dec 22, 2005. Male patient, 66 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer stage iiib and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, condition aggravated, depressed level of consciousness, dysphoria, fall , pancreatitis, pericardial effusion, tonic convulsion. Gemzar dosage: 1700 MG OTHER INTRAVENOUS. During the same period patient was treated with NAVELBINE, CHLORIDE, AZASETRON HYDROCHLORIDE, DECADRON, SOLULACT, SOLDEM, OMEPRAZOLE. Patient was hospitalized. Patient died on 10/09/2005.


Gemzar Side Effects Report #4549445-X
Gemzar side effect was reported by a Physician from on Dec 20, 2004. Male patient, 71 years of age, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, lymphangiosis carcinomatosa, metastases to lung, pneumonitis, pulmonary artery thrombosis, urinary retention. Gemzar dosage: 1300 MG OTHER. During the same period patient was treated with NAVELBINE, MS CONTIN, FENTANYL, GASTER, PREDNISOLONE, ISONIAZID, BACTRAMIN, CLARITHROMYCIN. Patient died on 11/29/2004.

Gemzar Side Effects Report #4950555-3
Gemzar side effect was reported by a Physician from JAPAN on Mar 01, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, blood pressure decreased, condition aggravated, hyperthermia, malignant ascites, malignant neoplasm progression, peritonitis. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. Patient died on 12/11/2005.

Gemzar Side Effects Report #4570751-7
Gemzar side effect was reported by a Physician from on Jan 17, 2005. Male patient, 69 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, confusional state, disorientation, emphysema, non-small cell lung cancer, personality change, pneumonia , respiratory failure. Gemzar dosage: 1900 MG. During the same period patient was treated with DOCETAXEL, RANITIDIN, DEXAMETHASONE, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4752425-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 08, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthma , c-reactive protein increased, condition aggravated, no therapeutic response, pneumonia . Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with NAVELBINE. Patient died on 06/01/2005.

Gemzar Side Effects Report #4765589-1
Gemzar side effect was reported by a Physician from JAPAN on Aug 24, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthma , condition aggravated, pneumonia . Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with NAVELBINE. Patient died on 06/01/2005.


Gemzar Side Effects Report #4871002-6
Gemzar side effect was reported by a Physician from GERMANY on Dec 20, 2005. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, peripheral arterial occlusive disease. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, BETA BLOCKING AGENTS, ACE INHIBITOR NOS, INSULIN, SELENIUM. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4871022-1
Gemzar side effect was reported by a Physician from GERMANY on Dec 20, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arterial occlusive disease, condition aggravated. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN, BETA BLOCKING AGENTS, ACE INHIBITOR NOS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4882933-5
Gemzar side effect was reported by a Physician from GERMANY on Jan 06, 2006. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arterial occlusive disease, condition aggravated, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. During the same period patient was treated with BETA BLOCKING AGENTS, ACE INHIBITOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4588106-8
Gemzar side effect was reported by a Physician from on Jan 28, 2005. Male patient, 64 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , budd-chiari syndrome, condition aggravated, gallbladder enlargement, gastrointestinal haemorrhage, hepatic cirrhosis, hepatic pain. Gemzar dosage: 2000 MG. During the same period patient was treated with CARBOPLATIN, FLUVOXAMINE MALEATE, RISPERDAL, SPIRONOLACTONE, FUROSEMIDE, PREDNISOLONE. Patient died on 01/13/2005.

Gemzar Side Effects Report #4983236-0
Gemzar side effect was reported by a Physician from JAPAN on Apr 03, 2006. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, lung disorder, pneumonitis. Gemzar dosage: 1600 MG, OTHER, INTRAVENOUS. During the same period patient was treated with NAVELBINE. Patient died on 10/31/2005.

Gemzar Side Effects Report #4626575-5
Gemzar side effect was reported by a Physician from on Mar 14, 2005. Female patient, 55 years of age, weighting 149.9 lb, was diagnosed with metastases to lung and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, dyspnoea, hypoxia, infection , inflammation, lung infiltration, respiratory distress, urticaria. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4629672-3
Gemzar side effect was reported by a Physician from on Mar 17, 2005. Female patient, 63 years of age, weighting 176.4 lb, was diagnosed with malignant urinary tract neoplasm and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, arteriovenous fistula, chest pain , circulatory collapse, condition aggravated, crohn's disease , febrile neutropenia, grand mal convulsion. Gemzar dosage: 1830 MG. During the same period patient was treated with CARBOPLATIN, WARFARIN, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 04/30/2002.

Gemzar Side Effects Report #4578538-6
Gemzar side effect was reported by a Physician from on Jan 21, 2005. Male patient, 63 years of age, was diagnosed with lymphoma  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchiolitis, condition aggravated, obstructive airways disorder. Gemzar dosage: unknown. During the same period patient was treated with ELOXATIN, RITUXIMAB, ONCOVORIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, MABTHERA, PREDNISONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4692395-9
Gemzar side effect was reported by a Physician from on May 31, 2005. Male patient, 63 years of age, was diagnosed with lymphoma  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchiolitis, condition aggravated. Gemzar dosage: unknown. During the same period patient was treated with ELOXATIN, RITUXIMAB, ONCOVIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, MABTHERA, PREDNISONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4625655-8
Gemzar side effect was reported by a Physician from on Mar 16, 2005. Male patient, 67 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, gout , joint swelling, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with VINORELBINE TARTRATE. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4710770-0
Gemzar side effect was reported by a Physician from JAPAN on June 22, 2005. Male patient, 67 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, gout , pyrexia. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with NAVELBINE, ZOFRAN, FIRSTCIN, NAIXAN, MUCOSTA, LENDORM. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4698498-7
Gemzar side effect was reported by a Physician from on June 08, 2005. Female patient, 70 years of age, weighting 123.5 lb, was diagnosed with lung adenocarcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, dermatitis allergic, pneumonia , renal failure, tachycardia. Gemzar dosage: 865 MG/M2/2 OTHER. During the same period patient was treated with CISPLATIN, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 05/20/2005.

Gemzar Side Effects Report #4738534-2
Gemzar side effect was reported by a Physician from JAPAN on July 07, 2005. Male patient, 51 years of age, weighting 141.1 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, acute stress disorder, blood pressure diastolic decreased, candidiasis, condition aggravated, crackles lung, disseminated intravascular coagulation, enterococcal infection, haemoptysis. Gemzar dosage: 1700 MG OTHER. During the same period patient was treated with CARBOPLATIN. Patient died on 12/16/2003.

Gemzar Side Effects Report #4988634-7
Gemzar side effect was reported by a Physician from JAPAN on Apr 12, 2006. Female patient, 70 years of age, was diagnosed with gastric cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cancer pain, carbohydrate antigen 19-9 increased, condition aggravated, disseminated intravascular coagulation, metastases to bone marrow, metastatic gastric cancer, nausea . Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 04/01/2005.

Gemzar Side Effects Report #4872750-4
Gemzar side effect was reported by a Physician from JAPAN on Dec 22, 2005. Female patient was diagnosed with gallbladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, glare, visual acuity reduced. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4870915-9
Gemzar side effect was reported by a Pharmacist from JAPAN on Dec 13, 2005. Female patient was diagnosed with cervix carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, metastases to lung, pericardial effusion, pneumonitis. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with PARAPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4619442-4
Gemzar side effect was reported by a Physician from on Mar 03, 2005. Female patient, 63 years of age, was diagnosed with breast cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, palmar-plantar erythrodysaesthesia syndrome. Gemzar dosage: unknown. During the same period patient was treated with TAXOL, XELODA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4619438-2
Gemzar side effect was reported by a Physician from on Mar 03, 2005. Female patient, 49 years of age, was diagnosed with breast cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, palmar-plantar erythrodysaesthesia syndrome. Gemzar dosage: unknown. During the same period patient was treated with TAXOL, XELODA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4631203-9
Gemzar side effect was reported by a Physician from on Mar 21, 2005. Female patient, 49 years of age, weighting 169.8 lb, was diagnosed with breast cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, dermatitis exfoliative, palmar-plantar erythrodysaesthesia syndrome. Gemzar dosage: 1250 MG/M2. During the same period patient was treated with TAXOL, XELODA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4959096-0
Gemzar side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2006. Female patient, 54 years of age, weighting 192.7 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion, dyspnoea, haematocrit decreased, haemoglobin decreased, neuropathy peripheral, pleural effusion, tremor. Gemzar dosage: unknown. During the same period patient was treated with TAXOTERE, ZOLOFT, PRILOSEC, CALCIUM WITH VITAMIN D, GLUCOSAMINE, ATIVAN, VITAMIN B. Patient recovered.


Gemzar Side Effects Report #4900377-4
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 16, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, hypoxia, neutrophil count decreased, pulmonary toxicity, pyrexia, rales, respiratory syncytial virus infection , white blood cell count decreased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4848760-X
Gemzar side effect was reported by a Physician from FRANCE on Nov 23, 2005. Female patient, 75 years of age, weighting 88.18 lb, was diagnosed with breast cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, pleural effusion. Gemzar dosage: 4080 MG, OTHER, INTRAVENOUS. During the same period patient was treated with TRIATEC, EPREX, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5478563-7
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 26, 2007. Male patient, 64 years of age, was diagnosed with biliary cancer metastatic, bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthma , condition aggravated, cryptogenic organising pneumonia, malignant neoplasm progression, pneumothorax. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4900765-6
Gemzar side effect was reported by a Physician from JAPAN on Jan 16, 2006. Male patient, 76 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, condition aggravated, lung disorder, platelet count decreased, pleural effusion, pneumocystis jiroveci pneumonia, pneumonia viral, pneumonitis, respiratory failure. Gemzar dosage: unknown. During the same period patient was treated with GASTER D, RINDERON, GASTROM, SEROTONE. Patient died on 10/26/2005.

Gemzar Side Effects Report #4608773-X
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Female patient, 62 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, haemoglobin decreased, haemolysis. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with METRONIDAZOLE, CIPROFLOXACIN, DUROGESIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4613257-9
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Female patient, 62 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, haemolysis, thrombocytopenia. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with METRONIDAZOLE, CIPROFLOXACIN, DUROGESIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4949467-0
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 01, 2006. Female patient, 67 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, condition aggravated, ovarian cancer, pneumonia , respiratory disorder. Gemzar dosage: 2000MG,. Patient was hospitalized. Patient died on 11/10/2005.

Gemzar Side Effects Report #4951182-4
Gemzar side effect was reported by a Physician from AUSTRALIA on Mar 03, 2006. Female patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, embolic stroke, lung infection, lung neoplasm malignant, neutropenia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, DEXAMETHASONE, VITAMIN B12. Patient was hospitalized. Patient died on 12/13/2005.

Gemzar Side Effects Report #4954770-4
Gemzar side effect was reported by a Physician from AUSTRALIA on Mar 03, 2006. Female patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, infection , lung neoplasm malignant, neutropenia, pleural effusion, therapeutic response decreased, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, DEXAMETHASONE, VITAMIN B12. Patient was hospitalized. Patient died on 12/13/2005.

Gemzar Side Effects Report #4760334-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 12, 2005. Male patient, 50 years of age, weighting 119.0 lb, was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph decreased, condition aggravated, constipation , dyspnoea, hemiplegia, hypercapnia, pco2 decreased, pco2 increased, pneumothorax. Gemzar dosage: 1200 MG OTHER. During the same period patient was treated with CARBOPLATIN. Patient recovered.